An investigation on behalf of investors in Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares over potential wrongdoing at Bellerophon Therapeutics was announced and NASDAQ:BLPH stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 11/01/2016 --Certain directors of Bellerophon Therapeutics Inc are under investigation over potential wrongdoing. The investigation was announced for investors in NASDAQ:BLPH shares over possible breaches of fiduciary duties by certain directors at Bellerophon Therapeutics Inc .

Investors who purchased shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Bellerophon Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

On July 27, 2015, Bellerophon Therapeutics Inc announced top-line results from its PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix (BCM), an investigational, implantable medical device being studied for the prevention of heart failure following an acute myocardial infarction (AMI), commonly known as a heart attack. Bellerophon Therapeutics Inc said that topline results of the 303-patient, randomized, double-blind, placebo-controlled study, enrolled at 61 clinical sites in Australia, Europe, Israel and North America, showed no statistically significant treatment differences between patients treated with BCM and patients treated with placebo for both the primary and the secondary endpoints.

Shares of Bellerophon Therapeutics Inc (NASDAQ:BLPH) declined from as high as $12 per share in February 2015 to as low as $1.09 per share in May 2016.

On October 31, 2016, NASDAQ:BLPH shares closed at $1.17 per share.

Those who purchased shares of Bellerophon Therapeutics Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739